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(From the Center/or Cancer Research and the Department o/Biology,  Massachusetts  Institute o/ 
Technology,  Cambridge, Massachusetts  02139) 
Recent advances in the knowledge of antibody structure have prompted much dis- 
cussion  of the  number  and  arrangement  of the  genes which  code for immuno- 
globulin light and heavy chains (6, 12). In no case, however, have immunoglobulin 
structural  genes been located in a  genetic linkage  map of any organism.  Knowl- 
edge of the  linkage  groups containing  immunoglobulin  structural  loci would be 
useful in further analyzing by genetic and other methods the number and disposi- 
tion  of germ  line variable (V)  region  genes responsible for the enormous amino 
acid sequence diversity observed in immunoglobulin chains. 
Edelman  and  Gottlieb  have  described  a  genetic  marker  in  the  V  region  of 
mouse  immunoglobulin  light  chains  (4,  5).  The  marker,  called  the  I B-peptide 
marker, was detected as a unique zone of radioactivity in peptide maps of tryptic 
digests of fully reduced  [14C]iodoacetic acid-alkylated light chains isolated from 
unimmunized  mice.  Amino  acid  sequence analysis  showed that  these  peptides 
contain  the half-cystinyl residue at position 23 of the light chains,  and breeding 
studies  indicated  that  the  expression  of these  unique  peptides  segregates  in  a 
fashion  consistent  with  the  behavior  of  a  classical  Mendelian  marker.  In  a 
I B-positive strain,  the I B-peptide marker  is present  in approximately 5% of the 
light  chains  and  it  is  absent  from  lambda  chains.  In  heterozygotes  between 
I B-positive and  I B-negative  strains,  the  marker  is  expressed  at  approximately 
half  the  level  of I B-positive  homozygotes.  The  simplest  interpretation  for  the 
existence  of  this  light-chain  V-region  genetic  marker  is  that  it  represents  a 
polymorphism in structural  genes coding for light-chain V regions. Alternatively, 
the presence or absence of the I B-peptide marker  may reflect polymorphism  in 
a  gene  which  influences  the  expression  of light-chain  V  regions  (e.g.  a  regula- 
tory gene, an endogenous virus, etc.). 
In  order  to  identify  the  locus  or linkage  group  responsible  for  expression  of 
this  light  chain  V-region marker,  the inbred and congenic strain  distribution  of 
the  I B-peptide  marker  has  been compared with the strain  distribution  of other 
known  genetic  markers  (7).  The  present  communication  reports  an  absolute 
positive  correlation  between  the  IB-peptide  marker  and  the  Ly-3.1  thymocyte 
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cell surface antigen, and indicates genetic linkage of the I B-peptide marker to the 
Ly-2 and Ly-3 loci in linkage group XI on chromosome 6 of the mouse. (1, 2, 8). 
Materials and Methods 
Mice and Sera.  Inbred strains and pooled frozen serum were obtained from the Jackson Labora- 
tories, Bar Harbor, Maine. Serum and breeding stock of the C57BL/6-Ly-2aLy-3 a strain (9) were the 
generous gift of Dr.  E.  A.  Boyse,  Sloan-Kettering Institute for Cancer Research, New York.  AKR. 
B6/1  mice, derived by Boyse and co-workers (9), were the gift of Dr. H. O. McDevitt, Stanford Uni- 
versity School of Medicine, Stanford, Calif'. Serum from AKR.M mice was kindly supplied by Dr. 
G. D.  Snell, Jackson Laboratories, Bar Harbor, Maine. 
Preparation of  Immunoglobulins, Light  Chains, and  Peptide  Maps.  Immunoglobulins  from 
pooled sera were obtained by starch zone electrophoresis in sodium barbital buffer, pH 8.6 (5), fol- 
lowed by two successive gel filtrations on Sephadex G-200 (Pharmacia Fine Chemicals, Inc., Uppsala, 
Sweden). Isolation of light chains, complete reduction and alkylation with  [l'C]iodoacetic acid, di- 
gestion with trypsin, and preparation and autoradiography of peptide maps have been described (5). 
Absorption of AKR/J Serum.  4  ml of freshly prepared AKR/J serum were absorbed for 30 rain 
at 4°C with a 0.6-ml packed vol of washed AKR/J thymocytes (7:1, vol/vol). The cells were then re- 
moved by centrifugation, and the absorbed serum was applied to a starch block along with a separate 
sample of 4 ml of untreated AKR/J serum. IgG and light chains were obtained from each sample, and 
peptide maps were prepared. 
Results 
Genetic  Correlation  of  IB  and  Ly-3.1.  The  distribution  of  the  I B-peptide 
marker among 27 inbred and congenic strains  of mice is shown in Table I. The 
four inbred strains,  AKR/J, C58/J, RF/J, and PL/J, that express the I B-peptide 
marker  in  their  immunoglobulin  light  chains  also express the  Ly-3.1 antigenic 
specificity on the surface of their thymocytes. None of the I B-negative strains ex- 
presses the Ly-3.1 antigenic  specificity. The C57BL/6-Ly-2aLy-3  a strain (Ly-2.1, 
Ly-3.1  positive)  was derived by Boyse and  co workers to be congenic  with the 
I B-negative C57BL/6 strain  (Ly-2.2, Ly-3.2 positive) at all but the region of the 
Ly-2 and Ly-3 loci (9). The Ly-2.1 and Ly-3.1 alleles were supplied by strain RF 
and the mice were inbred after 16 backcrosses to C57BL/6 (E. A. Boyse, personal 
communication).  C57BL/6-Ly-2aLy-3  ~ immunoglobulin  light  chains were found 
TABLE I 
Expression of I~-Peptide Marker in Inbred Strains of Mice 
Express I R-peptide marker*  Lack IB-peptide markers 
AKR/J 
C58J 
RF/J 
PL/J 
AKR.B6/1 
C57BL/6-Ly-2aLy-3  a 
DBA/2J  CE/J  C57Br/cdJ 
DBA/1J  SJL/J  C57L/J 
A/J  SWR/J  CBA/J 
A/HeJ  NZB  BALB/cJ 
C3H/HeJ  ST/bJ  MA/J 
C57BL/6J  BDP/J  SEA/GnJ 
C57BL/KsJ  129/J  AKR.M 
* Thymocytes from  strains  in  this  column  have  been  determined to  be  positive for the  Ly-3.1 
antigenic specificity (1). 
S Thymocytes from strains in this column have been determined to be positive for the Ly-3.2  anti- 
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to be I B positive,  indicating  that  expression of the  I B-peptide marker is closely 
linked to the Ly-2 and Ly-3 loci selected in the derivation of this strain. 
Since  three  of the  four  inbred  strains  expressing  the  I~,-peptide marker also 
possess  the  H-2 ~ genotype  (Table  II),  it  was  important  to  test  tbr any  possible 
linkage  to  the  H-2  locus,  the  major histocompatibility  locus  of the  mouse.  The 
inbred  strain  AKR.B6/1  is  congenic  to  AKR at  all  but  the  H-2  locus  where  it 
is H-2 ~ instead of H-2 k (9). This strain was I, positive, indicating that expression 
of the  IB-peptide  marker  is  not  linked  to  the  H-2 k  genotype.  In  addition,  the 
non-H-2  k  strains,  PL/J  (H-2")  and  C57BL/6-Ly-2aLy-3  a  (H-2 ~)  are  In  posi- 
tive. Since the Ir-1 locus governing the immune response to a number of antigens 
is closely linked to the H-2 locus (10),  the I B-peptide marker would appear to be 
unlinked to it as well. 
TABLE II 
Characteristics o[ Several Inbred Strains o[ Mice at Selected Genetic Loci 
STRAIN  IB*  Ly-l$  Ly-2$  Ly-3$  H-25  05 
AKR/J  +  2  1  1  k  AKR 
C58/J  +  2  1  1  k  C3H 
RF/J  +  2  1  1  k  AKR 
PL/J  +  2  1  1  u  AKR 
C57BL/6-  +  2  I  1  b  C3H 
Ly-2aLy-3  a 
AKR.B6/1  +  2  1  1  b  AKR 
C57BL/6J  2  2  2  b  C3H 
CE/J  -  2  1  2  k  C3H 
* IB, expression of I~-peptide marker in light chains; (+) present and (-) absent. 
$ (Data from references 1 and 13). Ly-1, Ly-2, and Ly-3, number indicates allele present;  1, allele 1 
and 2, allele 2. H-2,  haplotype at H-2 locus. 0, 0-antigen allele. 
Absorption  with  Thymocytes.  The  possibility was  considered that  immuno- 
globulin containing I ~-positive light chains might be autoantibody directed against 
the Ly-3.1 antigenic  specificity. Extensive absorption of serum from the I B-posi- 
tive  strain  AKR/J  with  washed  AKR/J  thymocytes  (Ly-3.1  positive)  fhiled  to 
remove  the  I B-containing  immunoglobulin  components  as  revealed  by  subse- 
quent peptide mapping of light chains. 
Discussion 
The  results  indicate  that  a  locus  governing  the  expression  of  the  I~-peptide 
marker  is  genetically linked  to the  locus governing the  expression of the  Ly-3.1 
thymocyte  surface  antigen.  Moreover,  preliminary  peptide  mapping  studies  of 
light chains from AKXL recombinant inbred strains derived by Taylor et al. (14) 
indicate that the expression of the I B-peptide marker is genetically linked to the 
Ly-2 and  Ly-3 loci in these strains as well (P.  D.  Gottlieb and  B. A. Taylor, un- 
published  observations).  Itakura  and  co-workers  have  shown  (8)  that  the  Ly-3 
locus  is  extremely  closely  linked  to  the  Ly-2  locus  in  linkage  group  XI of the 
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progeny.  Since the Ly-3.1 allele appears always to be associated with the Ly-2.1 
allele,  all  I B-positi~e  mice  are  also  Ly-2.1  positive.  The  I R-peptide  marker  is 
therefore  linked  to  the  Ly-2.1,  Ly-3.1  genotype.  That  the  IB-peptide  marker 
is correlated with Ly-3.1 rather than  Ly-2.1 is demonstrated by such strains as 
CE/J (Table II), which is Ly-2.1 positive, Ly-3.2 positive, and I ~ negative. 
A primary goal of these studies is to discern the nature of the locus governing 
expression  of the  I B-peptide  marker.  The  simplest  hypothesis  is  that  it  is  a 
structural  locus  coding  for  light-chain  V  regions.  The  expression  in  IB heter- 
ozygotes of approximately half as much I B-peptide marker as in I B homozygotes 
could then be simply explained as a  gene dosage effect. Alternatively,  a  genetic 
locus linked to or identical  to Ly-3.1 may regulate the expression of light-chain 
V-region structural genes encoded elsewhere in the genome (7). 
The possibility was considered that I u-positive immunoglobulin might represent 
autoantibody to the Ly-3.1 thymocyte antigenic specificity since autoantibodies 
to thymocytes have been detected in several strains  of mice (11).  However, at- 
tempts  to  adsorb  I B-positive immunoglobulin  with  Ly-3.1-positive thymocytes 
were unsuccessful, making autoantibody to Ly-3.1 an unlikely explanation. 
The extremely close genetic linkage observed between the Ly-2 and Ly-3 loci 
led Itakura et al. to suggest (8) that they comprise a complex genetic locus (Ly-2, 
3)  characterized  by multiple  specificities.  Moreover,  studies  by Boyse and  co- 
workers (1,  3) using the antibody blocking method suggested a  close topological 
relationship between Ly-2 and Ly-3 antigenic specificities on the thymocyte sur- 
face, and led to the suggestion that the Ly-2 and Ly-3 antigens may reside on the 
product  of a  single  gene  (8).  These  characteristics  of the  Ly-2,3  chromosomal 
region  and  antigenic  specificitics  are  remarkably  similar  to  what  one  might 
expect  for  a  complex  chromosomal  region  coding  for  immunoglobulin  V  and 
C  regions (6).  The intriguing  possibility must be considered that the I B-peptide 
marker in immunoglobulin light chains may be coded for by the Ly-3.1 locus, and 
that the Ly-3 and perhaps Ly-2 antigenic specificities might reside on molecules 
structurally related to immunoglobulins. 
Finally,  it may be significant  that  in all the characterized  inbred strains,  the 
Ly-2.2,  Ly-3.1  haploid  chromosome  has  not  been  observed,  whereas  the  other 
three  combinations  have been  identified  (Table II).  The absence of the Ly-2.2, 
Ly-3.1  chromosome  may  reflect  some  inherent  lethality  of this  chromosome, 
or may be due to chance in the derivation  of laboratory mice. In this regard, a 
careful  survey of wild  mice for the  missing chromosome would be informative. 
However,  the  absence  of  the  Ly-2.2,  Ly-3.1  chromosome  may  reflect  the 
evolutionary pathway that  gave rise to the  chromosomes bearing linkage  group 
X! of the mouse. For example, the pathways shown in Fig. 1 would preclude the 
existence of the missing chromosome. 
The close genetic linkage of the I B-peptide marker in mouse immunoglobulin 
light  chains  to  the  Ly-2  and  Ly-3  loci  (or  Ly-2,3  complex  locus)  specifying 
thymocyte surface antigens  strongly  suggests  that  this  chromosomal  region  in 
linkage  group  XI  may be  intimately  involved  in  the  function  of the  immune 
system. Further dissection of this genetic region and of the molecules specified by 
it  should  therefore bear upon  the  mechanisms  which underlie  the immune  re- 
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LY-2,1,  LY-3,1 
OR  OR  I 
I 
I 
LY-2,1,  LY-3,2 
LY-2,2,  1_¥-3,2 
Fro.  1.  Evolutionary  model to account for absence of Ly-2.2, Ly-3.1 chromosome. Single, 
double, and dotted arrows denote three possible evolutionary pathways which would preclude 
the existence of the Ly-2.2, Ly-3.1  chromosome. 
Summary 
The  inbred  and  congenic  strain  distribution  of the  IR-peptide  marker  in  the 
variable  region of mouse  immunoglobulin light  chains has been  compared with 
other  known  genetic  markers.  A  positive  correlation  was  noted  between  the 
I B-peptide  marker and  expression  of the Ly-3.1 thymocyte cell  surface antigen. 
This  suggests  that  the  locus responsible for I ~-peptide expression  is  genetically 
linked  to  the  Ly-2  and  Ly-3  loci  in  linkage  group  XI on  chromsome 6  of the 
mouse. 
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